2. 
Alzheimer's disease is a progressive
neurologic disease of the brain leading
to the irreversible loss of neurons and the
loss of intellectual abilities, including
memory and reasoning, which become
severe enough to impede social or
occupational functioning

3. According the National Institute on
Aging, there are estimated to be
between 2.4 million and 4.5 million
Americans who have Alzheimer's
 Deaths from Alzheimer's have risen by
68% from 2000 to 2010 and18 million
people worldwide suffer Alzheimer’s
disease.
 The Alzheimer’s Disease Foundation of
Malaysia estimates that there currently
about 50,000 people with Alzheimer’s
disease.


4. 
Age

Age is the greatest known risk factor for
Alzheimer’s Disease after the age of 65;
individuals aged 80 and above have a one in
four chance.

Family history

happen to people who have a close family like
parent, sibling or child member who
developed Alzheimer's have a slightly higher
risk of developing it themselves

5. Down's syndrome
 People with Down's syndrome have an
extra copy of chromosome 21, which
contains a protein that exists in the brain
of people with Alzheimer’s
 Cardiovascular Disease
 happen to an individual suffers a
condition that damages either the heart
or the blood vessels such as cardiac
disease, stroke, high blood pressure or
diabetes.


6. Memory loss that interferes with daily
functioning.
 patients have particular difficulty
remembering recently learned
information.
 Loss of planning and problem-solving
ability
 individuals may find it difficult to
strategies and develop a plan of section


7. Problems with speaking or writing .
 They knowledge of recent occasions or
current events is decreased and they
have problem to reading a passage and
retaining information from it.
 Confusion with time and place.
 individuals may lose track of dates and
time and they may not understand what
is happening at the moment or how they
arrived at the certain place.


8. Neuropsychological testing.
 These types of tests are extremely useful
in detecting Alzheimer’s as well as other
dementias early.
 MRI (magnetic resonance imaging)
scans.
 these types of tests scan is conducted to
assess the integrity of neural tissues in the
fronto-temporal regions of the brain.


9. 

PET (positron emission tomography) scan
A PET scan that measures uptake of
sugar in the brain significantly improves
the accuracy of diagnosing a type of
dementia often mistake for Alzheimer’s
disease.

10. 


Various medications.
can help to slow down the progression of
the disease and can improve the signs
and symptoms.
Example of medication such as
cholinesterase inhibitors, this function is to
improve levels of neurotransmitters in the
brain.

11. Controlling the disease’s progression
 preserving cognitive function and
generating some influence over
stabilizing changes in patient’s mood
and personality.
 Pharmaceutical intervention .
 to help manage the symptoms
associated with loss of cognitive
function, behavioral changes and even
possible insomnia faced by patients.


12. 

Pharmacological therapies.
use of antidepressants to stabilize anxiety
and restlessness, and antipsychotic
preparations for controlling hallucination,
delusions and aggressive behavior that
focus on treating the behavioral.